GW Pharma (GWPH) Posts Q3 Loss of 6c/Share; THCV Phase 2 Missed Primary Endpoint in T2D
Go back to GW Pharma (GWPH) Posts Q3 Loss of 6c/Share; THCV Phase 2 Missed Primary Endpoint in T2D| GW PHARM SP ADS (NASDAQ: GWPH) | Delayed: 218.96 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $218.96 | 52 Week High | $137.88 | |||
| Open | $1.76 | 52 Week Low | $35.83 | |||
| Day High | $218.96 | P/E | N/A | |||
| Day Low | $218.96 | EPS | $0.00 | |||
| Volume | 172,734 | |||||

